LMAT LeMaitre Vascular, Inc.
$84.31▼ -0.17%
Healthcare
Other
Volume 270.6K
Avg Volume (10D) 253.2K
Key Metrics & Fundamentals
Market Cap
$1.93B
P/E Ratio
29.6
Div Yield
1.19%
52W Range
78.22 - 118.01
% vs 50 MA
3.90%
% vs 200 MA
-10.77%
RSI-14
57.2
MACD Histogram
+0.4500
Beta (1Y vs SPY)
0.41
Free Cash Flow
$13.65M
Gross Rev
$70.38M
Gross Profit
$50.76M
EBITDA
$26.15M
COGS
$19.62M
Operating Exp
$30.37M
Operating Income
$20.40M
EBIT
$20.40M
Pretax Income
$22.19M
Net Income
$17.05M
EPS (Diluted)
0.74
Price & Volume History
Loading chart…
Recent News
3 cash-heavy stocks walking a fine line
StockStory · Oct 22, 2026 3:17 PM ET
LeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026
GlobeNewswire · Oct 12, 2026 4:49 PM ET
1 of Wall Street’s Favorite Stocks to Own for Decades and 2 We Brush Off
StockStory · Oct 6, 2026 5:04 AM ET
Is LeMaitre Vascular (LMAT) A Bargain Following Its 90 Day Pullback?
Simply Wall St. · Sep 24, 2026 6:15 PM ET
LeMaitre Vascular (LMAT) Stock Looks Fully Priced On Its 57% Five Year Run
Simply Wall St. · Sep 23, 2026 11:25 PM ET
3 Small-Cap Stocks We Steer Clear Of
StockStory · Sep 22, 2026 6:13 AM ET
2 Profitable Stocks to Target This Week and 1 We Ignore
StockStory · Sep 21, 2026 5:18 AM ET
3 Out-of-Favor Stocks with Questionable Fundamentals
StockStory · Sep 4, 2026 3:58 AM ET
PAHC or LMAT: Which Is the Better Value Stock Right Now?
Zacks · Sep 2, 2026 11:40 AM ET
Speculative Rally Weighed on LeMaitre Vascular (LMAT)
Insider Monkey · Sep 1, 2026 9:06 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See LMAT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.